CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Balance at beginning of period (in shares) at Feb. 03, 2024		545,973,529
Balance at beginning of period at Feb. 03, 2024	$ 915,147	$ 32	$ 2,368,597	$ 1,616	$ (1,455,098)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for vesting of RSUs (in shares)		14,077,918
Issuance of common stock for vesting of RSUs	2	$ 2
Issuance of common stock in connection with equity compensation plans (in shares)		1,146,308
Issuance of common stock in connection with equity compensation plans	16,959		16,959
Shares withheld related to net share settlement of RSUs (in shares)		(140)
Shares withheld related to net share settlement of RSUs	(7)		(7)
Stock-based compensation expense	212,355		212,355
Other comprehensive income (loss)	(1,616)			(1,616)
Net income (loss)	(143,705)				(143,705)
Balance at end of period (in shares) at Nov. 02, 2024		561,197,615
Balance at end of period at Nov. 02, 2024	999,135	$ 34	2,597,904	0	(1,598,803)
Balance at beginning of period (in shares) at Aug. 03, 2024		556,361,204
Balance at beginning of period at Aug. 03, 2024	964,683	$ 33	2,524,042	1,605	(1,560,997)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for vesting of RSUs (in shares)		4,617,756
Issuance of common stock for vesting of RSUs	1	$ 1
Issuance of common stock in connection with equity compensation plans (in shares)		218,795
Issuance of common stock in connection with equity compensation plans	36		36
Shares withheld related to net share settlement of RSUs (in shares)		(140)
Shares withheld related to net share settlement of RSUs	(7)		(7)
Stock-based compensation expense	73,833		73,833
Other comprehensive income (loss)	(1,605)			(1,605)
Net income (loss)	(37,806)				(37,806)
Balance at end of period (in shares) at Nov. 02, 2024		561,197,615
Balance at end of period at Nov. 02, 2024	999,135	$ 34	2,597,904	0	(1,598,803)
Balance at beginning of period (in shares) at Feb. 01, 2025		565,719,239
Balance at beginning of period at Feb. 01, 2025	1,069,196	$ 35	2,680,012	(846)	(1,610,005)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for vesting of RSUs (in shares)		10,642,167
Issuance of common stock in connection with equity compensation plans (in shares)		642,651
Issuance of common stock in connection with equity compensation plans	18,745		18,745
Stock-based compensation expense	242,923		242,923
Other comprehensive income (loss)	3,646			3,646
Net income (loss)	(31,155)				(31,155)
Balance at end of period (in shares) at Nov. 01, 2025		577,004,057
Balance at end of period at Nov. 01, 2025	1,303,355	$ 35	2,941,680	2,800	(1,641,160)
Balance at beginning of period (in shares) at Aug. 02, 2025		573,634,637
Balance at beginning of period at Aug. 02, 2025	1,214,773	$ 35	2,861,440	2,224	(1,648,926)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for vesting of RSUs (in shares)		3,342,853
Issuance of common stock in connection with equity compensation plans (in shares)		26,567
Issuance of common stock in connection with equity compensation plans	8		8
Stock-based compensation expense	80,232		80,232
Other comprehensive income (loss)	576			576
Net income (loss)	7,766				7,766
Balance at end of period (in shares) at Nov. 01, 2025		577,004,057
Balance at end of period at Nov. 01, 2025	$ 1,303,355	$ 35	$ 2,941,680	$ 2,800	$ (1,641,160)